A Phase 3, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effects of Bexagliflozin Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 12 Mar 2018
At a glance
- Drugs Bexagliflozin (Primary) ; Metformin; Sitagliptin
- Indications Type 2 diabetes mellitus
- Focus Registrational; Therapeutic Use
- Sponsors Theracos
- 22 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 06 Nov 2017 Status changed from not yet recruiting to recruiting.
- 05 Sep 2017 Planned initiation date changed from 1 Aug 2017 to 1 Oct 2017.